Impact of multidrug resistance-related protein 3 gene silenced by siRNA on the drug resistance of liver cancer cells
Zheng Su, Bo Liu, Jianping Liu, Huayao Zhang, Zejian Lyu
Abstract
Zheng Su, Bo Liu, Jianping Liu, Huayao Zhang, Zejian Lyu
Abstract
Objective To observe the impact of multidrug resistance-related protein (MRP) 3 gene silenced by small interfering RNA (siRNA) (MRP3-siRNA) on the drug resistance of primary liver cancer cells. Methods The drug resistance cell lines HepG2/Adriamycin(ADM) were developed by exposing parental cells to stepwise increasing concentrations of ADM and then MRP3-siRNAs were transfected in HepG2/ADM cells with lipofectamine 2000 liposomes. Three groups were assigned: HepG2 cell group (control group), HepG2/ADM cell group (resistance group) and MRP3-siRNA transfected HepG2/ADM cell group (interference group). The MRP3 mRNA contents of 3 groups were measured by real-time fluorescent quantitative polymerase chain reaction (PCR). The expression of MRP3 protein was detected by Western blot. The 50% inhibitory concentrations (IC50) of ADM, fluorouracil (5-FU), vincristine, oxaliplatin were determined by methyl thiazolyl tetrazolium (MTT) and the drug resistance indexes (RI) were calculated. The experimental data of 3 groups were compared by one-way analysis of variance, while pairwise comparisons were conducted using LSD-t or t test. Results The mean of MRP3 mRNA content in resistance group (5.16±0.31) was significantly higher than those in control group (3.08±0.27) and interference group (2.85±0.23) (LSD-t=8.765, 10.363; P<0.05). The MRP3 protein content in resistance group (21 063±274) was significantly higher than those in control group (14 476±217) and interference group (6 660±153) (LSD-t=21.836, 79.578; P<0.05). The RI of ADM, 5-FU,vincristine, oxaliplatin in resistance group were 14.40±0.31, 26.68±0.22, 28.70±0.49, 20.23±0.54, and were 3.55±0.16, 9.60±0.27, 2.11±0.17, 3.15±0.13 respectively in interference group. The RI in interference group were significantly lower than those in resistance group (t=53.873, 84.933, 88.811, 53.258; P<0.05). Conclusions MRP3 gene of liver cancer cells silenced by siRNA can improve the cells' sensitivity to chemotherapy drugs and reverse its chemotherapy drug resistance. Key words: Liver neoplasms, experimental; RNA interference; Multidrug resistance-associated proteins
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the impact of multidrug resistance-related protein (MRP) 3 gene silenced by small interfering RNA (siRNA) (MRP3-siRNA) on the drug resistance of primary liver cancer cells. Methods The drug resistance cell lines HepG2/Adriamycin(ADM) were developed by exposing parental cells to stepwise increasing concentrations of ADM and then MRP3-siRNAs were transfected in HepG2/ADM cells with lipofectamine 2000 liposomes. Three groups were assigned: HepG2 cell group (control group), HepG2/ADM cell group (resistance group) and MRP3-siRNA transfected HepG2/ADM cell group (interference group). The MRP3 mRNA contents of 3 groups were measured by real-time fluorescent quantitative polymerase chain reaction (PCR). The expression of MRP3 protein was detected by Western blot. The 50% inhibitory concentrations (IC50) of ADM, fluorouracil (5-FU), vincristine, oxaliplatin were determined by methyl thiazolyl tetrazolium (MTT) and the drug resistance indexes (RI) were calculated. The experimental data of 3 groups were compared by one-way analysis of variance, while pairwise comparisons were conducted using LSD-t or t test. Results The mean of MRP3 mRNA content in resistance group (5.16±0.31) was significantly higher than those in control group (3.08±0.27) and interference group (2.85±0.23) (LSD-t=8.765, 10.363; P<0.05). The MRP3 protein content in resistance group (21 063±274) was significantly higher than those in control group (14 476±217) and interference group (6 660±153) (LSD-t=21.836, 79.578; P<0.05). The RI of ADM, 5-FU,vincristine, oxaliplatin in resistance group were 14.40±0.31, 26.68±0.22, 28.70±0.49, 20.23±0.54, and were 3.55±0.16, 9.60±0.27, 2.11±0.17, 3.15±0.13 respectively in interference group. The RI in interference group were significantly lower than those in resistance group (t=53.873, 84.933, 88.811, 53.258; P<0.05). Conclusions MRP3 gene of liver cancer cells silenced by siRNA can improve the cells' sensitivity to chemotherapy drugs and reverse its chemotherapy drug resistance. Key words: Liver neoplasms, experimental; RNA interference; Multidrug resistance-associated proteins
Key concepts: Transfection, Lipofectamine, Molecular biology, Oxaliplatin, Multiple drug resistance, Small interfering RNA, Western blot, Chemistry